Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Abpro Holdings Inc. (ABPO) vs Carisma Therapeutics Inc. (CARM)

Abpro Holdings Inc. and Carisma Therapeutics Inc. are both Biotechnology companies. Abpro Holdings Inc. and Carisma Therapeutics Inc. are of similar size ($1.5M and $1.4M). Carisma Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.2×. Carisma Therapeutics Inc. has the higher net margin (14.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Abpro Holdings Inc. leads on 6 and Carisma Therapeutics Inc. on 4.

Valuation

Metric ABPO CARM Biotechnology median
P/E 0.20 n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.41 n/m 0.74
EV/Sales n/m (0.05) 10.73
Earnings yield 500.00% 0.00% (28.84%)
Free cash flow yield (311.42%) 0.00% (23.03%)

Profitability

Metric ABPO CARM Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 19.36% 0.00%
Net margin 0.00% 14.36% 0.00%
Free cash flow margin 0.00% (38.79%) 0.00%
Return on equity (20.18%) (134.11%) (57.72%)
Return on assets 46.10% 33.09% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABPO CARM Biotechnology median
Revenue growth (TTM) — 170.48% 5.64%
EPS growth (last fiscal year) 94.15% 43.68% —
Revenue growth, 5-year CAGR — 115.24% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABPO CARM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.62 0.86 4.73
Net debt to EBITDA 0.01 0.30 0.96

Dividend

Metric ABPO CARM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABPO CARM Biotechnology median
Market cap 1.42m 1.52m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack